Talk to Us

Anthem Blue Cross and Blue Shield Nevada prior authorization, page 74

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
J7330Cultured Chondrocytes ImplntNevada Prior Authorization List, Pg 152 Original policy
J7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 mlNevada Prior Authorization List, Pg 152 Original policy
J7351Injection, bimatoprost, intracameral implant, 1 microgramNevada Prior Authorization List, Pg 152 Original policy
J7352Afamelanotide implant, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J7353Anacaulase-bcdb, 8.8% gel, 1 gmNevada Prior Authorization List, Pg 152 Original policy
J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)Nevada Prior Authorization List, Pg 152 Original policy
J7355Injection, travoprost, intracameral implant, 1 mcgNevada Prior Authorization List, Pg 152 Original policy
J7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mgNevada Prior Authorization List, Pg 152 Original policy
J7402Mometasone furoate sinus implant, (sinuva), 10 microgramsNevada Prior Authorization List, Pg 152 Original policy
J7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mgNevada Prior Authorization List, Pg 152 Original policy
J9011Injection, datopotamab deruxtecan-dlnk, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9015Injection, aldesleukin, per single use vialNevada Prior Authorization List, Pg 152 Original policy
J9021Injection, asparaginase, recombinant, (rylaze), 0.1 mgNevada Prior Authorization List, Pg 152 Original policy
J9022Injection, atezolizumab, 10 mgNevada Prior Authorization List, Pg 152 Original policy
J9023Injection, avelumab, 10 mgNevada Prior Authorization List, Pg 152 Original policy
J9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjsNevada Prior Authorization List, Pg 152 Original policy
J9026Injection, tarlatamab-dlle, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramNevada Prior Authorization List, Pg 152 Original policy
J9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic doseNevada Prior Authorization List, Pg 152 Original policy
J9032Injection, belinostat, 10 mgNevada Prior Authorization List, Pg 152 Original policy
J9033Injection, bendamustine hydrochloride, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9034Injection, bendamustine hcl (bendeka), 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9035Bevacizumab injectionNevada Prior Authorization List, Pg 152 Original policy
J9036Injection, bendamustine hydrochloride, (Belrapzo), 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9038Injection, axatilimab-csfr, 0.1 mgNevada Prior Authorization List, Pg 152 Original policy
J9039Injection, blinatumomab, 1 microgramNevada Prior Authorization List, Pg 152 Original policy
J9042Injection, brentuximab vedotin, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9043Injection, cabazitaxel, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9047Injection, carfilzomib, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9055Cetuximab injectionNevada Prior Authorization List, Pg 152 Original policy
J9056Injection, bendamustine hydrochloride (vivimusta), 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9057Injection, copanlisib, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9061Injection, amivantamab-vmjw, 2 mgNevada Prior Authorization List, Pg 152 Original policy
J9063Injection, mirvetuximab soravtansine-gynx, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9064Injection, cabazitaxel (Sandoz), not therapeutically equivalent to J9043, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9118Injection, calaspargase pegol-mknl, 10 unitsNevada Prior Authorization List, Pg 152 Original policy
J9119Injection, cemiplimab-rwlc, 1 mgNevada Prior Authorization List, Pg 152 Original policy
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihjNevada Prior Authorization List, Pg 153 Original policy
J9145Injection, daratumumab, 10 mgNevada Prior Authorization List, Pg 153 Original policy
J9161Injection, denileukin diftitox-cxdl, 1 mcgNevada Prior Authorization List, Pg 153 Original policy
J9173Injection, durvalumab, 10 mgNevada Prior Authorization List, Pg 153 Original policy
J9176Injection, elotuzumab, 1 mgNevada Prior Authorization List, Pg 153 Original policy
J9177Injection, enfortumab vedotin-ejfv, 0.25 mgNevada Prior Authorization List, Pg 153 Original policy
J9179Injection, eribulin mesylate, 0.1 mgNevada Prior Authorization List, Pg 153 Original policy
J9183Gemcitabine intravesical system, 225 mgNevada Prior Authorization List, Pg 153 Original policy
J9202Goserelin Acetate ImplantNevada Prior Authorization List, Pg 153 Original policy
J9203Injection, gemtuzumab ozogamicin, 0.1 mgNevada Prior Authorization List, Pg 153 Original policy
J9207Injection, ixabepilone, 1 mgNevada Prior Authorization List, Pg 153 Original policy
J9210Injection, emapalumab-lzsg, 1 mgNevada Prior Authorization List, Pg 153 Original policy
J9216Injection, interferon, gamma-1B, 3 million unitsNevada Prior Authorization List, Pg 153 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.

This website uses cookies to ensure you get the best experience on our website. Learn more